Americans Travel to Mexico for Stem Cell Stimulation Therapies and E+ Peptide Cancer Vaccine -- Treatments Not Yet Offered in U.

KIRKLAND, Wash., Aug. 9, 2011 /PRNewswire/ -- Many Americans – unsatisfied with traditional treatments for cancer, diabetes, osteoporosis, and other intractable diseases – are looking south for advanced remedies. "We're struggling to keep up with demand," says Dr. Oscar E. Castro, head of Regenerative Cellular Therapy (RCT),, of Puerto Penasco, Sonora, Mexico.

Located on the grounds of the luxury Bella Sirena resort,, RCT focuses on regenerative cellular therapy and natural pharmaceutical-quality bio-medications to optimize one's energy and cell nutrition.

These processes stimulate stem cells using peptides and peptones.  The effect is to eradicate the signs and symptoms of diseases more quickly and more effectively than medulla stem cell protocols. Each of the treatments exerts an effective preventative and curative action.  "This occurs because the peptide and peptone treatments allow us to specifically target the organ that is affected," stated Dr. Castro.

The use of peptides and peptones stimulates the patient's stem cells, bringing results with unparalleled speed and intensity. The treatments are non-invasive and do not present any risk to the patient's health, nor are there any negative secondary side effects or allergic reactions.

RCT's peptide and peptone laboratories have been in their fields for over thirty years. "These laboratories continue to develop new therapies which have succeeded in having the dysfunctional cells of the recipient regenerate for their repair and revitalization within the strictest and most rigorous controls exacted by bio-safety," says Dr. Castro.

In addition to treating symptoms, RCT's bio-medications empower one's cell tissue structure and organs, avoiding the connection of the symptoms to the disease, thus making the body fit to withstand functional stress loads during the treatment. All of this is done through correcting the biological process of the disease's source and its side effects.

The two treatments receiving the most attention at RTC are the Peptide and E+ Peptide Cancer Vaccine. These treatments are now being used to treat:

  • Diabetes
  • Anti-Aging
  • Rheumatoid Arthritis
  • Cirrhosis
  • Cancer
  • Scleroderma
  • Leukemia
  • Lupus
  • Kidney Failure
  • Osteoporosis

RCT's E+ Peptide Cancer Vaccine is the key to tumor destruction.  By conducting an exchange of information through the p53 gene, the gene then orders cellular self-destruction rather than multiplication, a process called apoptosis.

RCT does not offer services stateside, but the procedures are common in other parts of the world. "Our treatments have the phone ringing off the hook," says Dr. Castro, "and we're developing a backlog to service as many patients as we can."

More information is available at, contact @, 480-626-4845 (USA office) or 638-382-8011 (Mexico office). An informational brochure may be downloaded at

LOGO 72dpi:

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R).

SOURCE Regenerative Cellular Therapy

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.